Red Light Holland Initiates Psilocybin Extraction Phase With PharmAla Following Successful Testing and Preparation by CCrest Labs

With the successful testing and preparation of our psilocybin truffles at CCrest Labs, we are now moving into an exciting phase of extraction with PharmAla.

newsfileApr 23 08:11 ET

Press Release: PharmAla Closes Private Placement and Concurrent Debt Settlement

PharmAla Closes Private Placement and Concurrent Debt Settlement VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDM

Dow JonesApr 19 08:35 ET

PharmAla Biotech Signs Sale Agreement With Numinus Wellness

PharmAla Biotech Holdings Inc. (MDMA.CN) had entered into a binding sales agreement with Numinus Wellness Inc. (NUMI.TO) to provide its GMP LaNeo MDMA for a prospective clinical trial. PharmAla also

MT NewswiresMar 26 09:20 ET

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

PharmAla Biotech Holdings Inc. (MDMA.CSE), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo MDMA and novel MDXX compounds, and Filament Health Corp.,

MT NewswiresNov 15, 2023 12:28 ET

PharmAla Biotech Received First Office Action for PharmAla-1 PCT Filing

PharmAla Biotech Holdings Inc. (MDMA.CSE), a biotechnology company working on MDXX class molecules (including MDMA), on Monday announced that it has received the first office action from the Patent Co

MT NewswiresSep 25, 2023 10:37 ET

PharmAla Biotech Filed Patent for Novel MDXX Molecule PharmAla-1

PharmAla Biotech Holdings Inc. (MDMA.CSE), a biotechnology company working on MDXX class molecules (including MDMA), on Monday said it has filed a patent on the composition of matter of PharmAla-1. Th

MT NewswiresJul 31, 2023 11:28 ET